Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 844

    1.

    Salutary effect of pigment epithelium-derived factor in diabetic nephropathy: evidence for antifibrogenic activities.

    Wang JJ, Zhang SX, Mott R, Knapp RR, Cao W, Lau K, Ma JX.

    Diabetes. 2006 Jun;55(6):1678-85.PMID: 16731830 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy.

    Wang JJ, Zhang SX, Mott R, Chen Y, Knapp RR, Cao W, Ma JX.

    Am J Physiol Renal Physiol. 2008 May;294(5):F1166-73. Epub 2008 Mar 5.PMID: 18322021 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Decreased expression of pigment epithelium-derived factor is involved in the pathogenesis of diabetic nephropathy.

    Wang JJ, Zhang SX, Lu K, Chen Y, Mott R, Sato S, Ma JX.

    Diabetes. 2005 Jan;54(1):243-50.PMID: 15616035 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli.

    Wahab NA, Schaefer L, Weston BS, Yiannikouris O, Wright A, Babelova A, Schaefer R, Mason RM.

    Diabetologia. 2005 Dec;48(12):2650-60. Epub 2005 Nov 4.PMID: 16270194 [PubMed - indexed for MEDLINE]Related articles

    5.

    Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis.

    Riser BL, Denichilo M, Cortes P, Baker C, Grondin JM, Yee J, Narins RG.

    J Am Soc Nephrol. 2000 Jan;11(1):25-38.PMID: 10616837 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Roles of connective tissue growth factor and prostanoids in early streptozotocin-induced diabetic rat kidney: the effect of aspirin treatment.

    Makino H, Mukoyama M, Sugawara A, Mori K, Suganami T, Yahata K, Fujinaga Y, Yokoi H, Tanaka I, Nakao K.

    Clin Exp Nephrol. 2003 Mar;7(1):33-40.PMID: 14586741 [PubMed - indexed for MEDLINE]Related articles

    8.

    Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy.

    Wang S, Denichilo M, Brubaker C, Hirschberg R.

    Kidney Int. 2001 Jul;60(1):96-105.PMID: 11422741 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy.

    Wahab NA, Yevdokimova N, Weston BS, Roberts T, Li XJ, Brinkman H, Mason RM.

    Biochem J. 2001 Oct 1;359(Pt 1):77-87.PMID: 11563971 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Expression of matrix metalloproteinases MMP-2 and MMP-9 is altered during nephrogenesis in fetuses from diabetic rats.

    Van Huyen JP, Viltard M, Nehiri T, Freund N, Bélair MF, Martinerie C, Lelongt B, Bruneval P, Lelièvre-Pégorier M.

    Lab Invest. 2007 Jul;87(7):680-9. Epub 2007 May 14.PMID: 17496904 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Lovastatin inhibits transforming growth factor-beta1 expression in diabetic rat glomeruli and cultured rat mesangial cells.

    Kim SI, Han DC, Lee HB.

    J Am Soc Nephrol. 2000 Jan;11(1):80-7.PMID: 10616843 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Mechanisms through which bradykinin promotes glomerular injury in diabetes.

    Tan Y, Wang B, Keum JS, Jaffa AA.

    Am J Physiol Renal Physiol. 2005 Mar;288(3):F483-92.PMID: 15692059 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Spironolactone ameliorates renal injury and connective tissue growth factor expression in type II diabetic rats.

    Han KH, Kang YS, Han SY, Jee YH, Lee MH, Han JY, Kim HK, Kim YS, Cha DR.

    Kidney Int. 2006 Jul;70(1):111-20. Epub 2006 May 24.PMID: 16723984 [PubMed - indexed for MEDLINE]Related articles

    14.

    Therapeutic potential of angiostatin in diabetic nephropathy.

    Zhang SX, Wang JJ, Lu K, Mott R, Longeras R, Ma JX.

    J Am Soc Nephrol. 2006 Feb;17(2):475-86. Epub 2006 Jan 4.PMID: 16394111 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells.

    Isono M, Chen S, Hong SW, Iglesias-de la Cruz MC, Ziyadeh FN.

    Biochem Biophys Res Commun. 2002 Sep 6;296(5):1356-65.PMID: 12207925 [PubMed - indexed for MEDLINE]Related articles

    16.

    Kidney involvement in a nongenetic rat model of type 2 diabetes.

    Danda RS, Habiba NM, Rincon-Choles H, Bhandari BK, Barnes JL, Abboud HE, Pergola PE.

    Kidney Int. 2005 Dec;68(6):2562-71.PMID: 16316331 [PubMed - indexed for MEDLINE]Related articles

    17.

    Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.

    Lee EA, Seo JY, Jiang Z, Yu MR, Kwon MK, Ha H, Lee HB.

    Kidney Int. 2005 May;67(5):1762-71.PMID: 15840023 [PubMed - indexed for MEDLINE]Related articles

    18.

    Connective tissue growth factor mediates high glucose effects on matrix degradation through tissue inhibitor of matrix metalloproteinase type 1: implications for diabetic nephropathy.

    McLennan SV, Wang XY, Moreno V, Yue DK, Twigg SM.

    Endocrinology. 2004 Dec;145(12):5646-55. Epub 2004 Sep 2.PMID: 15345671 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice.

    Roestenberg P, van Nieuwenhoven FA, Joles JA, Trischberger C, Martens PP, Oliver N, Aten J, Höppener JW, Goldschmeding R.

    Am J Physiol Renal Physiol. 2006 Jun;290(6):F1344-54. Epub 2005 Dec 27.PMID: 16380465 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes.

    Guha M, Xu ZG, Tung D, Lanting L, Natarajan R.

    FASEB J. 2007 Oct;21(12):3355-68. Epub 2007 Jun 6.PMID: 17554073 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data